Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 2, 2007, Pages 81-85

  Sivaprakasam, Ponni ^a   Carr, Trevor F ^a   Coussons, Mary ^a   Khalid, Tasneem ^a   Bailey, Andrew S ^a   Guiver, Malcolm ^a   Mutton, Kenneth J ^a   Turner, Andrew J ^a   Grainger, John D ^a   Wynn, Robert F ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Adenovirus; Bone marrow transplant; Immune reconstitution

Indexed keywords

ALEMTUZUMAB; ANTIVIRUS AGENT; CIDOFOVIR; PROBENECID; RIBAVIRIN;

ADENOVIRUS; ADOLESCENT; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE COURSE; DONOR; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EARLY INTERVENTION; FECES ANALYSIS; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDRATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PATIENT MONITORING; PEDIATRICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T CELL DEPLETION; TREATMENT OUTCOME; VIROLOGY; VIRUS INFECTION;

ADENOVIRUS INFECTIONS, HUMAN; ADOLESCENT; ANTIVIRAL AGENTS; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CYTOSINE; FECES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; INFANT; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN;

EID: 33846839258     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318030875e     Document Type: Article

References (20)

1. Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis. 2003;3:79-86.
2. Chakrabarti S, Mautner V, Osman H, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood. 2002;100:1619-1627.
3. Kampmann B, Cubitt D, Walls T, et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol. 2005;130:595-603.
4. Bordigoni P, Carret AS, Venard V, et al. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2001;32:1290-1297. [Epub April 10, 2001.]
5. Hoffmann JA, Shah AJ, Ross LA, et al. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7:388-394.
6. Legrand F, Berrebi D, Houhou N, et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant. 2001;27:621-626.
7. Lion T, Baumgartinger R, Watzinger F, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood. 2003;102:1114-1120. [Epub April 17, 2003.]
8. Ljungman P, Lore K, Aschan J, et al. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients. Bone Marrow Transplant. 1996;17:583-587.
9. Skapova D, Racil Z, Dvorakova D et al. Significance of qualitative PCR detection method for preemptive therapy of cytomegalovirus infection in patients after allogeneic hematopoietic stem cell transplantation - single-centre experience. Neoplasma. 2005;52:137-142.
10. Gavin PJ, Katz BZ. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics. 2002;110(1 Pt 1):e9.
11. Cooper RJ, Yeo AC, Bailey AS, et al. Adenovirus polymerase chain reaction assay for rapid diagnosis of conjunctivitis. Invest Ophthalmol Vis Sci. 1999;40:99-95.
12. Koncul I, Raos M, Krizanac S, et al. Bronchopneumonia, obstructive bronchitis and bronchiectasis in children with adenovirus infections. Lijec Vjesn. 1997;119:11-15. [Croatian.]
13. Chuang YY, Chiu CH, Wong KS, et al. Severe adenovirus infection in children. J Microbiol Immunol Infect. 2003;36:37-40.
14. Myers GD, Krance RA, Weiss H, et al. Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant. 2005; [Epub ahead of print].
15. Shields AF, Hackmann RC, Fife KH, et al. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med. 1985;312:529-533.
16. Feuchtinger T, Lang P, Hamprecht K, et al. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. Exp Hematol. 2004;32:282-289.
17. Feuchtinger T, Lucke J, Hamprecht K, et al. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2005;128:503-509.
18. Leen AM, Rooney CM. Adenovirus as an emerging pathogen in immunocompromised patients [Review]. Br J Haematol. 2005;128:135-144.
19. Amrolia PJ, Muccioli-Casadei G, Yvon E, et al. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood. 2003;102:2292-2299. [Epub May 22, 2003; Erratum in: Blood. 2004;104:1605.]
20. Khan SA, Moreb JS. Reversal of severe graft-versus-host disease after nonmyeloablative matched unrelated donor stem cell transplant by infusion of backup autologous peripheral blood stem cells. Bone Marrow Transplant. 2005;36:267-268.